Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.11
WILYY's Cash to Debt is ranked lower than
55% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. WILYY: 0.11 )
WILYY' s 10-Year Cash to Debt Range
Min: 0.06   Max: No Debt
Current: 0.11

Equity to Asset 0.49
WILYY's Equity to Asset is ranked higher than
57% of the 447 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. WILYY: 0.49 )
WILYY' s 10-Year Equity to Asset Range
Min: 0.11   Max: 0.49
Current: 0.49

0.11
0.49
F-Score: 7
Z-Score: 4.25
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 18.72
WILYY's Operating margin (%) is ranked higher than
93% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. WILYY: 18.72 )
WILYY' s 10-Year Operating margin (%) Range
Min: 19.32   Max: 24.99
Current: 18.72

19.32
24.99
Net-margin (%) 13.91
WILYY's Net-margin (%) is ranked higher than
91% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. WILYY: 13.91 )
WILYY' s 10-Year Net-margin (%) Range
Min: 12.7   Max: 17.71
Current: 13.91

12.7
17.71
ROE (%) 25.87
WILYY's ROE (%) is ranked higher than
98% of the 445 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. WILYY: 25.87 )
WILYY' s 10-Year ROE (%) Range
Min: 28.67   Max: 163.09
Current: 25.87

28.67
163.09
ROA (%) 12.61
WILYY's ROA (%) is ranked higher than
93% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. WILYY: 12.61 )
WILYY' s 10-Year ROA (%) Range
Min: 13.69   Max: 32.18
Current: 12.61

13.69
32.18
ROC (Joel Greenblatt) (%) 52.12
WILYY's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. WILYY: 52.12 )
WILYY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 56.42   Max: 188.5
Current: 52.12

56.42
188.5
Revenue Growth (%) 11.30
WILYY's Revenue Growth (%) is ranked higher than
86% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. WILYY: 11.30 )
WILYY' s 10-Year Revenue Growth (%) Range
Min: -46.7   Max: 15.4
Current: 11.3

-46.7
15.4
EBITDA Growth (%) 8.00
WILYY's EBITDA Growth (%) is ranked higher than
82% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. WILYY: 8.00 )
WILYY' s 10-Year EBITDA Growth (%) Range
Min: -45.2   Max: 18.4
Current: 8

-45.2
18.4
EPS Growth (%) 11.00
WILYY's EPS Growth (%) is ranked higher than
82% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. WILYY: 11.00 )
WILYY' s 10-Year EPS Growth (%) Range
Min: -43.6   Max: 17.7
Current: 11

-43.6
17.7
» WILYY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with WILYY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.00
WILYY's P/E(ttm) is ranked higher than
92% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 85.90 vs. WILYY: 20.00 )
WILYY' s 10-Year P/E(ttm) Range
Min: 12.03   Max: 40.08
Current: 20

12.03
40.08
P/B 5.11
WILYY's P/B is ranked higher than
66% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.88 vs. WILYY: 5.11 )
WILYY' s 10-Year P/B Range
Min: 4.63   Max: 68.81
Current: 5.11

4.63
68.81
P/S 2.84
WILYY's P/S is ranked higher than
74% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.41 vs. WILYY: 2.84 )
WILYY' s 10-Year P/S Range
Min: 1.91   Max: 41.24
Current: 2.84

1.91
41.24
PFCF 28.76
WILYY's PFCF is ranked higher than
88% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 28.76 )
WILYY' s 10-Year PFCF Range
Min: 25.77   Max: 341.02
Current: 28.76

25.77
341.02
EV-to-EBIT 15.96
WILYY's EV-to-EBIT is ranked higher than
91% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 64.69 vs. WILYY: 15.96 )
WILYY' s 10-Year EV-to-EBIT Range
Min: 8.4   Max: 195.3
Current: 15.96

8.4
195.3
PEG 2.62
WILYY's PEG is ranked higher than
93% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 2.62 )
WILYY' s 10-Year PEG Range
Min: 0.82   Max: 6.25
Current: 2.62

0.82
6.25
Shiller P/E 25.08
WILYY's Shiller P/E is ranked higher than
94% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 25.08 )
WILYY' s 10-Year Shiller P/E Range
Min: 13.74   Max: 35.26
Current: 25.08

13.74
35.26
Current Ratio 0.82
WILYY's Current Ratio is ranked lower than
55% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. WILYY: 0.82 )
WILYY' s 10-Year Current Ratio Range
Min: 0.79   Max: 1.82
Current: 0.82

0.79
1.82
Quick Ratio 0.57
WILYY's Quick Ratio is ranked lower than
55% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. WILYY: 0.57 )
WILYY' s 10-Year Quick Ratio Range
Min: 0.51   Max: 1.06
Current: 0.57

0.51
1.06

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 17.75
WILYY's Price/Tangible Book is ranked higher than
59% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 6.71 vs. WILYY: 17.75 )
WILYY' s 10-Year Price/Tangible Book Range
Min: 20.01   Max: 152.09
Current: 17.75

20.01
152.09
Price/DCF (Projected) 2.30
WILYY's Price/DCF (Projected) is ranked higher than
87% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 2.30 )
WILYY' s 10-Year Price/DCF (Projected) Range
Min: 2.63   Max: 83.87
Current: 2.3

2.63
83.87
Price/Median PS Value 0.70
WILYY's Price/Median PS Value is ranked higher than
94% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. WILYY: 0.70 )
WILYY' s 10-Year Price/Median PS Value Range
Min: 0.59   Max: 8.54
Current: 0.7

0.59
8.54
Price/Peter Lynch Fair Value 2.62
WILYY's Price/Peter Lynch Fair Value is ranked higher than
96% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 2.62 )
WILYY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.9   Max: 5.28
Current: 2.62

1.9
5.28
Price/Graham Number 3.95
WILYY's Price/Graham Number is ranked higher than
79% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. WILYY: 3.95 )
WILYY' s 10-Year Price/Graham Number Range
Min: 4.51   Max: 14.59
Current: 3.95

4.51
14.59
Earnings Yield (Greenblatt) 6.30
WILYY's Earnings Yield (Greenblatt) is ranked higher than
91% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. WILYY: 6.30 )
WILYY' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.5   Max: 11.9
Current: 6.3

0.5
11.9
Forward Rate of Return (Yacktman) 9.81
WILYY's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.50 vs. WILYY: 9.81 )
WILYY' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -29.1   Max: 16.7
Current: 9.81

-29.1
16.7

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:0K7I.UK, WDH.Denmark, WDH.Germany,
William Demant Holding A/S was incorporated in Denmark. The Company is a hearing product and equipment manufacturer. The Company operates in three segments namely Hearing Aids, Diagnostic Instruments, and Personal Communication. The Hearing Aid segment offers hearing aids under the Oticon and Bernafon brand names. Oticon offers several hearing aid lines, including EPOQ, Dual, Vigo, Hit, Sumo DM, and products for the elderly. Bernafon offers many hearing aid lines, including Verite, Icos, Brite, Move, Swissear, Symbio XT, Prio, Xtreme, Avanti, Neo, and Win. The products range from affordable to premium depending on the features needed. The Diagnostic Instruments segment includes Maico Diagnostics, Interacoustics, and Amplivox. Maico offers audiometers, middle ear analyzers, BERAphones, OAE test systems, software, and services. Interacoustics offer audiometers, middle ear analyzers, HA fitting, VNG balance systems, and rhiometry. Amplivox provides manual and automatic screening audiometers, audiogram software, diagnostic audiometers, acoustic booths, electro acoustic ear simulator, tympanometers, middle ear analyzers, spirometers, vision screeners, audiocups, and accessories and consumables. The Personal Communication segment operates under Phonic Ear and Sennheiser Communications. Phonic Ear offers sound field systems, teleloop and loudspeaker systems, infrared systems, and assistive listening devices.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK